|
Preparation of an epidemiological response tool in the event of a sanitary crisis due to a chemical accident |
|
November 3, 2014 |
|
Risk and health impact assessment |
crises, accident chimique, préparation aux situations d’urgence, biomonitoring |
|
Accelerated Development of Vaccine Benefit-Risk Collaboration in Europe |
ADVANCE |
October 1, 2013 |
September 30, 2018 |
Epidemiology of infectious diseases, Quality of vaccines and blood products |
vaccination, immunisation, préventif, thérapeutique, pharmacovigilance, epidémiologie, surveillance, évaluation bénéfices/risques, patients |
|
European Joint Action of Frailty |
ADVANTAGE |
January 1, 2017 |
December 31, 2019 |
Lifestyle and chronic diseases |
frailty, older population, European Union, vulnerability, aging |
|
Development of new molecular biology methods for the quantification of airborne pollen in the context of aerobiological surveillance |
Allerpol |
January 1, 2016 |
December 31, 2019 |
Mycology and aerobiology , Transversal activities in applied genomics |
pollen, molecular biology, Real Time PCR, digital PCR |
|
Analysis of data on allergy in the Brussels Capital Region |
ALLRBC2 |
January 1, 2016 |
June 30, 2017 |
Risk and health impact assessment |
asthme, rhinite allergique, bases de données, médicaments, hospitalisations, décès |
|
Creation of a platform for methods used as alternatives to animal testing |
ALTDATA |
April 15, 2017 |
October 14, 2019 |
Risk and health impact assessment |
3R, replacement, alternative methods, in vitro, in silico, in chemico, new technologies |
|
Belgian Cystic Fibrosis Registry |
BCFR |
October 1, 2006 |
|
Health services research |
Cystic fibrosis, CF, Mucoviscidose, Registry, Quality of care |
|
Belgian National Burden of Disease Study |
BeBOD |
January 4, 2016 |
March 31, 2020 |
Lifestyle and chronic diseases |
disease burden, Disability-Adjusted Life Years, monitoring, prioritisation |
|
Virus-host interplay at the early stages of infection |
BELVIR |
October 1, 2012 |
September 30, 2017 |
Trace elements and nanomaterials |
myxoviruses, glycoproteins, TEM, attachment-fusion, mucus, GFP |
|
Bioavailability and transformation of arsenic from food: role of food preparation, preservation and digestion |
BIOTRAs |
February 1, 2012 |
January 31, 2015 |
Trace elements and nanomaterials |
Arseen, Arsenic, Speciatie, Speciation, Biotoegankelijkheid, Bioaccessibilité, Bioaccessibility, Risico-evaluatie, Evaluations des risques, risk evaluation, blootstelling, Exposition, exposure, Voedselbereiding, Préparation des aliments, Food preparation |
|
Belgian neuromuscular diseases registry |
BNMDR |
January 1, 2008 |
|
Health services research |
Maladies neuromusculaires, registre |
|
Antigenic drift in the surface proteins of the mumps virus and its impact on vaccine efficacy |
Bofvax |
January 1, 2014 |
December 31, 2018 |
Viral diseases, Immune response |
Mumps, vaccination, virus-neutralisation test, immunity, T cell, B cell, epitopes, antigenicity |
|
Better Training for Safer Food - Mycotoxins |
BTSF |
August 7, 2015 |
March 9, 2018 |
Organic contaminants and additives |
European Commission, mycotoxins, training course, food safety, import, harmonisation |
|
Preparation of CEN Technical Specification: “Guidance on detection and identification of nano-objects in complex matrices”(WI 00352012, CEN-TC352-WG3-PG2) |
CEN project |
September 1, 2014 |
December 31, 2017 |
Trace elements and nanomaterials |
Nano-objects, nano-objets, nano-objecten, complex matrix, matrice complexe, complexe matrix, guidance document, document de conseils, richtlijnen document |
|
A 12-years trend analysis of candidemia in Belgium: incidence, drug resistance and antifungal consumption |
CglabrataR |
January 1, 2014 |
December 31, 2017 |
Mycology and aerobiology , Healthcare-associated infections and antimicrobial resistance |
Candidemia, antifungal resistance, antifungal consumption, nosocomial diseases, yeast, fungi, mycology |
|
The incidence of citrinin in the Belgian food and feed chain and the risk for human and animal health |
CITRIRISK |
October 1, 2016 |
September 30, 2020 |
Organic contaminants and additives |
Mycotoxin, Citrinin, occurrence, food safety, feed, Belgium, toxicokinetics, broiler chickens, pigs, carry-over, biotransformation |
|
Analysis and risk characterisation for arsenic species in food supplements |
COMPAs |
November 1, 2015 |
October 31, 2016 |
Trace elements and nanomaterials |
food supplements, Compléments alimentaires, Voedingssumplementen, AS species, Spéciation de l'arsenic, intake, apport/consommation, inname, risk evaluation, evaluation des risques, risico evaluatie |
|
Characterisation and risk evaluation of counterfeit antibiotics on the European market |
counterfeit antibiotics |
October 1, 2016 |
October 1, 2020 |
Medicines and health products |
counterfeit antibiotics, quality control, impurities, market study |
|
Revision of the dermatophyte taxonomy |
DermatoTax |
January 1, 2016 |
December 31, 2019 |
Mycology and aerobiology |
dermatophytes, TAXONOMY, PHYLOGENY, MEDICAL MYCOLOGY, TINEA |
|
Characterisation and risk evaluation of electronic cigarettes and related products |
e-SMOKE |
November 3, 2015 |
November 2, 2019 |
Medicines and health products, Risk and health impact assessment |
e-cigarettes, quality control, nicotine replacement therapy, genotoxicity, mutagenicity |
|
Development of biomarkers for endocrine disruptors |
EDC BIRTHCOHORT |
April 1, 2015 |
December 31, 2017 |
Risk and health impact assessment |
endocrine disruptor, exposure, placenta, birth cohort |
|
Belgian Bioelectromagnetics Group |
ELIA2 |
July 1, 2013 |
July 1, 2017 |
Risk and health impact assessment |
electromagnetic fields, Alzheimer’s disease, genetic effects, project coordination, BBEMG |
|
Optimisation of virological and serological diagnosis as part of avian influenza monitoring in preparation for the emergence of new highly pathogenic (HP) viruses |
EMERDIAH5 |
January 1, 2017 |
December 31, 2017 |
Avian virology and immunology, Veterinary bacteriology |
influenza aviaire, diagnostic différentiel, surveillance, Luminex, ELISA |
|
Exposure Risk Assessments |
ERA |
January 1, 2004 |
|
Lifestyle and chronic diseases |
Voeding, additieven, contaminanten, blootstelling, risicobeoordeling |
|
European programme for the establishment of validated procedures for the detection and identification of biological toxins |
EuroBioTox |
June 1, 2017 |
May 31, 2022 |
Foodborne pathogens , Organic contaminants and additives |
detection identification and authentication, Chemical Biological Radiological and Nuclear (CBRN) protection, biological toxins, Standardisation, proficiency testing, certified reference materials, animal replacement methods |
|
Belgian national Food Consumption Survey |
FCS |
January 1, 2004 |
|
Lifestyle and chronic diseases |
Voeding, consumptie, voedingsmiddelen, gebruikelijke inname, vet, suiker, koolhydraten, eiwitten, energie, vitaminen, mineralen, zout, jodium, richtlijnen |
|
Modeling the absorption of cadmium in leaf and root crops |
FoodCad |
March 1, 2014 |
February 29, 2016 |
Trace elements and nanomaterials, Organic contaminants and additives |
cadmium, spinach, spinazie, épinards, carrots, wortelen, carottes, modeling, modellering, modelage, root uptake, wortelopname, extraite par les racines |
|
Evaluation of important aspects of the efficacy of inactivated and live attenuated lumpy skin disease vaccines for cattle |
GALVmed LSD |
November 15, 2016 |
November 14, 2018 |
Transversal activities in applied genomics, Exotic viruses and transmissible spongiform encephalopathies |
lumpy skin disease, inactivated vaccine, attenuated vaccine, duration of immunity and protection |
|
Human genomic biomarker RTqPCR array for optimized and mechanistically-based genotoxicity assessment |
GENOMARK |
May 1, 2014 |
April 30, 2017 |
Risk and health impact assessment, Transversal activities in applied genomics |
toxicogenetics, transcriptomics, DNA damage, genotoxicity tests, gene expression profiling, in vitro, 3R, alternative method |
|
Impact of green/blue spaces on specific morbidity and cause-specific mortality in Belgium |
GRESP-HEALTH |
December 15, 2014 |
March 15, 2019 |
Risk and health impact assessment |
environment, green space, blue space, morbidity, mortality, inequity |
